Abstract
Technetium-99m is the principal radioisotope used in medical diagnostics; radionuclidic impurity is the major concern of its quality. This work presents a analytical method for sequential determination of all radionuclidic impurities listed in pharmacopoeia including gamma emitters, alpha emitters, 89Sr and 90Sr. Radioactive decay for removal of 99mTc, ion exchange and extraction chromatography for removal of 99Mo and 99Tc are effective for separation of interferences. Gamma spectrometry, LSC with alpha/beta discrimination, and Cherenkov counting using LSC are sensitive methods for measurement of the impurity radionuclides. The detection limits of this method are well meet the requirement of the quality control according to the limitation of the pharmacopoeia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zolle I (2007) Technetium-99m pharmaceuticals, preparation and quality control in nuclear medicine. Springer, Berlin, Heidelberg, New York
Takács S, Szűcs Z, Tárkányi F, Hermanne A, Sonck M (2003) Evaluation of proton induced reactions on 100Mo: new cross sections for production of 99mTc and 99Mo. J Radioanal Nucl Chem 257(1):195–201
Directorate for the Quality of Medicine and Healthcare, Council of Europe (2014) Sodium pertechnetate (99mTc) injection (fission), p 1090. European Pharmacopoeia-8.0, Strasbourg Cedex. http://online6.edqm.eu/ep800/
United States Pharmacopeial Convention (2005) Official monographs: USP 28, sodium pertechnetate Tc-99m injection, p 1861. United States Pharmacopeia (USP) 28 (NF) 23
Andrade WG, Lima FF (2009) Evaluation of the eluate quality of 99Mo-99mTc generator in Receife, Brazil, International Nuclear Atlantic Conference - INAC 2009, Rio de Janeiro, 27 September–2 October
UAMS, College of Pharmacy, Nuclear pharmacy, Quality control procedure for free pertechnetate-99m. http://nuclearpharmacy.uams.edu/proc1.htm
Hammermaier A, Reich E, Bögl W (1986) Chemical, radiochemical and radionuclidic purity of eluates from different commerical fission 99Mo/99mTc generators. Eur J Nucl Med 12:41–46
Sodd VJ, Fortman DL (1976) Analysis of the 89Sr and 90Sr content in eluates of fission produced 99Mo–99mTc generator. Health Phys 30(2):179–182
Khan M, Jabbar T, Asif M, Anjum MI, Dilband M, Khan K, Jabbar A, Arshed W (2014) Radiostrontium separation from sodium molybdate solution and its measurement using LSA: an application to radiopharmaceutical analysis. J Radioanal Nucl Chem 299:577–582
Braun H, Hoffmann P, Lieser KH (1981) Determination of alpha and pure beta emitting impurities in 99Mo/99mTc generator eluates. J Radioanal Chem 67(1):215–220
Terlikowska T, Hainos D, Cassette P, Radosewski T (2000) Application of α/β discrimination in liquid scintillation counting for the purity control of 99mTc medical solutions. Appl Radiat Isot 52:627–632
Johansson L, Mattsson S (1980) Plutonium in technetium-99m labeled pertechnetate for clinic use. J Nucl Med 21(11):1091–1094
Directorate for the Quality of Medicine and Healthcare, Council of Europe (2014) Sodium molybdate (99Mo) solution (fission), p 1088. European Pharmacopoeia-8.0, Strasbourg Cedex
Lehto J, Hou XL (2010) Chemistry and analysis of radionuclides. Wiley-VCH, Weinheim
Acknowledgements
The author acknowledges prof. Mikael Jensen and Dr. Sven P. Nielsen from DTU Nutech for their suggestions and discussion during the method development. Dr. Dannis Ringkjøbing Elema helped to obtain and calibrate radionuclide standards.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hou, X. Determination of radionuclidic impurities in 99mTc eluate from 99Mo/99mTc generator for quality control. J Radioanal Nucl Chem 314, 659–668 (2017). https://doi.org/10.1007/s10967-017-5369-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-017-5369-9